MedPath

Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial

Completed
Conditions
ST Segment Elevation Myocardial Infarction
Myocardial Oedema
Interventions
Other: Cardiac magnetic resonance imaging
Registration Number
NCT01897350
Lead Sponsor
Elisa McAlindon
Brief Summary

Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain functional and anatomical information on the heart. Several CMR parameters measured after primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated as the myocardial oedema minus infarct size; this again is a prognostic indicator following STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences available, with no standardisation of sequences used to assess this surrogate endpoint. The investigators propose to conduct a study to measure the myocardial oedema by all available techniques to determine the agreement between these methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • STEMI
  • providing written informed consent
Exclusion Criteria
  • contraindication to CMR,
  • atrial fibrillation,
  • claustrophobia,
  • eGFR < 30

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CMR following ST segment myocardial infarctionCardiac magnetic resonance imaging-
Primary Outcome Measures
NameTimeMethod
The mass of myocardial oedema measured by CMRDay 2 following STEMI
Secondary Outcome Measures
NameTimeMethod
Extra cellular volumeDay 2 following STEMI

Trial Locations

Locations (1)

Bristol Heart Institute

🇬🇧

Bristol, Avon, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath